The 11th CABA MEDICAL DEVICE AND DIAGNOSTIC INNOVATION SYMPOSIUM
The 11st CABA Medical Device and Diagnostics Innovation Symposium (MDDI), co-sponsored by NECINA and HMS CSSA, is scheduled for Saturday, December 14th, 2019 at the Conference Center at Waltham Woods, 860 Winter St, Waltham, MA 02451.
The annual CABA MDDI Symposium is a major event attracting prominent entrepreneurs, investors, biotech and executives, academic and industry scientists, as well as professionals in the legal, finance, and healthcare fields locally and internationally. Past symposiums were extremely well attended. More than 200 professional attendees will be expected.
The theme of this symposium is “Precision Medicine”. Precision Medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. The point is that one data modality such as genomics, epigenetics, clinical - each of them by their own are insufficient. Look at patients at a multiaxial way will give us much better insight. Topics of this year’s symposium will include the academic concept of classifying human cells into subpopulations that differ in their susceptibility to CAR-T therapy; the application of artificial intelligence in kidney pathologic diagnosis; novel biomarker on clinical mass spectrometry to better manage maternity disease, etc.
- Wilson Zhang, CEO/ Milu Labs
- Thomas McLain, President & CCO / RenalytixAI
- Mingru Wu, Cancer Immunology & Virology; Dana-Farber Cancer Institute, Member of FacultyDepartment of Immunology; Harvard Medical School
- Shen Luan, Senior Director, Thermofisher Science
- Allena J. Ji, Director of Clinical Mass Spectrometry Laboratory, Sanofi
-- Sponsors --
-- Co-Organizers --
More information: www.cabaweb.org